KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cadre Holdings (CDRE) Asset Writedowns and Impairment (2020 - 2025)

Historic Asset Writedowns and Impairment for Cadre Holdings (CDRE) over the last 6 years, with Q3 2025 value amounting to -$230000.0.

  • Cadre Holdings' Asset Writedowns and Impairment fell 181666.67% to -$230000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$183000.0, marking a year-over-year decrease of 12328.24%. This contributed to the annual value of $764000.0 for FY2024, which is 105757.58% up from last year.
  • As of Q3 2025, Cadre Holdings' Asset Writedowns and Impairment stood at -$230000.0, which was down 181666.67% from $57000.0 recorded in Q2 2025.
  • Cadre Holdings' 5-year Asset Writedowns and Impairment high stood at $480000.0 for Q1 2024, and its period low was -$230000.0 during Q3 2025.
  • Moreover, its 5-year median value for Asset Writedowns and Impairment was $40000.0 (2023), whereas its average is $45736.8.
  • Its Asset Writedowns and Impairment has fluctuated over the past 5 years, first surged by 110000.0% in 2024, then plummeted by 181666.67% in 2025.
  • Cadre Holdings' Asset Writedowns and Impairment (Quarter) stood at $66000.0 in 2021, then skyrocketed by 160.61% to $172000.0 in 2022, then crashed by 83.14% to $29000.0 in 2023, then crashed by 75.86% to $7000.0 in 2024, then plummeted by 3385.71% to -$230000.0 in 2025.
  • Its Asset Writedowns and Impairment was -$230000.0 in Q3 2025, compared to $57000.0 in Q2 2025 and -$17000.0 in Q1 2025.